Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Menorrhagia × Progesterone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1 Menorrhagia 1 Leiomyoma 1 Infertility 1

Interventions

estradiol, norethindrone drug combination 9 elagolix 7 Estradiol 7 asoprisnil 6 relugolix 5 Norethindrone Acetate 5 vilaprisan 4 Uterine Myomectomy 3 linzagolix 2 Uterine Artery Embolization 2 ulipristal 1 Radiofrequency Ablation 1 Progesterone 1 Megestrol Acetate 1 Medroxyprogesterone Acetate 1 Electrocoagulation 1 Cryosurgery 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01441635 2021-07-13

Safety and Efficacy of Elagolix in Pre-Menopausal Women With Heavy Uterine Bleeding and Uterine Fibroids

AbbVie

Phase 2 Completed

271 enrolled 38 charts

Leiomyoma, Menorrhagia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡